ARTICLE | Company News
Galaxy, Roche deal
October 1, 2012 7:00 AM UTC
Galaxy granted the pharma exclusive, worldwide rights to develop and commercialize Galaxy's preclinical cancer antibodies targeting fibroblast growth factor 2 (FGF2). Galaxy will receive $8 million l...